IVVD Stock Analysis: Buy, Sell, or Hold?
IVVD - Invivyd, Inc. Common Stock
$0.54
-0.05 (-8.01%)
▼
5d:
-12.5%
30d:
-37.38%
90d:
-61.79%
WAIT
LOW Confidence
Analysis Updated: Jul 31, 2026 12:00 AM ET
Earnings: Aug 13, 2026
9d
Get Alerted When IVVD Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
⏸️ WAIT FOR STABILIZATION: IVVD is down 12.5% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
⏸️ WAIT FOR STABILIZATION: IVVD is down 12.5% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
In-depth Analysis How we analyze
Valuation Analysis: IVVD is currently trading at $0.54, which is considered oversold relative to its 30-day fair value range of $0.64 to $0.90.
Technical Outlook: Technically, IVVD is in a strong downtrend. The price is currently testing key support at $0.53. A bounce from this level would confirm strength, while a break below could signal further downside. Short-term momentum is weak, with the stock down 8.0% recently.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $10.00 (+1769.2%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, IVVD is in a strong downtrend. The price is currently testing key support at $0.53. A bounce from this level would confirm strength, while a break below could signal further downside. Short-term momentum is weak, with the stock down 8.0% recently.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $10.00 (+1769.2%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
OVERSOLD
Historical Trading Range
$0.64 -
$0.90
Company Quality Score
51/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
77.4%
All Signals
- BULLISH: Price oversold vs 30-day range
- NEUTRAL: Mixed technical signals (40/100)
- BULLISH: High volume confirmation
- BEARISH: Downward momentum (-8.0%)
- BULLISH: Trading 1769.2% below Wall St target ($10.00)
- WARNING: Recommendation downgraded due to -12.5% 5-day decline - wait for stabilization
Trading Range Analysis
30-Day Trading Range
$0.64 -
$0.90
Current vs Trading Range
OVERSOLD
Support & Resistance Levels
Support Level
$0.53
Resistance Level
$0.77
Current Trend
Strong Downtrend
Technical data as of
Jul 31, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-0.92
Wall Street Target
$10.00
(+1769.2%)
Revenue Growth (YoY)
21.6%
Profit Margin
-138.9%
Share & Embed Analysis
Last updated: August 03, 2026 2:16 AM ET
Data refreshes hourly during market hours. Next update: 3:16 AM
Data refreshes hourly during market hours. Next update: 3:16 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is IVVD showing a specific setup today?
Insider Activity (6 Months)
0
Buys
10
Sells
Net
INSIDERS SELLING
Recent Transactions
Julie Green
SELL
20964 shares
2026-02-18
Robert D Allen III
SELL
19392 shares
2026-02-18
Timothy Edward Lee
SELL
20964 shares
2026-02-18
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
IONS
Ionis Pharmaceuticals Inc |
BUY
26 analysts |
$89 | 59 HOLD |
|
RARE
Ultragenyx |
STRONG BUY
20 analysts |
$53 | 57 HOLD |
|
ACLX
Arcellx Inc |
STRONG BUY
18 analysts |
$113 | 57 HOLD |
|
RCKT
Rocket Pharmaceuticals I… |
STRONG BUY
18 analysts |
$9 | 57 HOLD |
|
ARVN
Arvinas Inc |
BUY
21 analysts |
$15 | 54 HOLD |
